[1]
M. Lahelma, “Real-life treatment patterns and time to next treatment among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland Study”, AO, vol. 63, no. 1, pp. 772–782, Oct. 2024.